- Home
- EVAX vs IMCC Comparison
EVAX vs IMCC Comparison
Compare EVAX & IMCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- IMCC
- Stock Information
- Founded
- EVAX 2008
- IMCC 1980
- Country
- EVAX Denmark
- IMCC Israel
- Employees
- EVAX N/A
- IMCC N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- IMCC Medicinal Chemicals and Botanical Products
- Sector
- EVAX Health Care
- IMCC Health Care
- Exchange
- EVAX Nasdaq
- IMCC Nasdaq
- Market Cap
- EVAX 15.1M
- IMCC 12.0M
- IPO Year
- EVAX 2021
- IMCC N/A
- Fundamental
- Price
- EVAX $2.64
- IMCC $2.95
- Analyst Decision
- EVAX Strong Buy
- IMCC
- Analyst Count
- EVAX 2
- IMCC 0
- Target Price
- EVAX $10.00
- IMCC N/A
- AVG Volume (30 Days)
- EVAX 103.4K
- IMCC 151.3K
- Earning Date
- EVAX 08-13-2025
- IMCC 08-13-2025
- Dividend Yield
- EVAX N/A
- IMCC N/A
- EPS Growth
- EVAX N/A
- IMCC N/A
- EPS
- EVAX N/A
- IMCC N/A
- Revenue
- EVAX $3,293,000.00
- IMCC $37,894,737.00
- Revenue This Year
- EVAX N/A
- IMCC $47.12
- Revenue Next Year
- EVAX N/A
- IMCC $12.83
- P/E Ratio
- EVAX N/A
- IMCC N/A
- Revenue Growth
- EVAX 2555.64
- IMCC 12.68
- 52 Week Low
- EVAX $1.20
- IMCC $1.29
- 52 Week High
- EVAX $17.75
- IMCC $7.12
- Technical
- Relative Strength Index (RSI)
- EVAX 55.56
- IMCC 51.60
- Support Level
- EVAX $2.26
- IMCC $2.37
- Resistance Level
- EVAX $2.60
- IMCC $3.75
- Average True Range (ATR)
- EVAX 0.21
- IMCC 0.38
- MACD
- EVAX -0.02
- IMCC 0.03
- Stochastic Oscillator
- EVAX 51.32
- IMCC 41.99
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.